Evidence map›Paper›PMID 28188565›Full record

ArticleInternational journal of bipolar disorders2017

Poor quality of life and functioning in bipolar disorder.

Louisa G Sylvia, Rebecca E Montana, Thilo Deckersbach, Michael E Thase, Maurcio Tohen, Noreen Reilly-Harrington, Melvin G McInnis, James H Kocsis, Charles Bowden, Joseph Calabrese and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of bipolar disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01331304 (Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01331304 phase4completednot on this map

Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder

TypeinterventionalSponsorMassachusetts General HospitalRan2010 to 2013Enrolled482ConditionsBipolar DisorderArmsLithium, Quetiapine
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 100 citations in OpenAlex.

  1. Home-based transcranial direct current stimulation (tDCS) for bipolar depression: effects on quality of life and functioning-an open-label study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Association between the epigenetic lifespan predictor GrimAge and history of suicide attempt in bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 1 country.

Louisa G SylviaDepartment of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA. lsylvia2@partners.org.
Rebecca E MontanaDepartment of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Thilo DeckersbachDepartment of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Michael E ThaseDepartment of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Maurcio TohenDepartment of Psychiatry and Behavioral Sciences, University of New Mexico, Health Sciences Center, Albuquerque, NM, USA.
Noreen Reilly-HarringtonDepartment of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Melvin G McInnisDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
James H KocsisDepartment of Psychiatry, Weill Cornell Medicine, New York City, NY, USA.
Charles BowdenDepartment of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Joseph CalabreseBipolar Disorders Research Center, University Hospital's Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Keming GaoBipolar Disorders Research Center, University Hospital's Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Terence KetterDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Richard C SheltonDepartment of Psychiatry, University of Alabama Birmingham School of Medicine, Birmingham, AL, USA.
Susan L McElroyLindner Center of HOPE, Mason, OH, USA.
Edward S FriedmanUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Dustin J RabideauBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Andrew A NierenbergDepartment of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Massachusetts General Hospital · USCase Western Reserve University · USCornell University · USLemuel Shattuck Hospital · USStanford University · USThe University of Texas Health Science Center at San Antonio · USUniversity Hospitals Case Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Cincinnati Medical Center · USUniversity of Michigan–Ann Arbor · USUniversity of New Mexico · USUniversity of Pennsylvania · USUniversity of Pittsburgh · US

Funding

Comparative Effectiveness Study for Bipolar DisorderR01HS019371 · AHRQ · MASSACHUSETTS GENERAL HOSPITAL · PI NIERENBERG, ANDREW A · 2010 to 2010
$9.8M
AHRQ HHS R01 HS019371
6 · The paper itself

Abstract

backgroundThis study explores the association of demographic and clinical features with quality of life and functioning in individuals with bipolar disorder.

methodsAdult participants (N = 482) with bipolar I or II disorder were enrolled in a comparative effectiveness study across eleven study sites and completed baseline measures of medical and psychiatric history, current mood, quality of life, and functioning. Participants with at least mildly depressive or manic/hypomanic symptomatic severity were randomized to receive lithium or quetiapine in addition to adjunctive personalized treatment for 6 months.

resultsParticipants with more severe depressive and irritability symptoms had lower quality of life and higher functional impairment. All psychiatric comorbid conditions except substance use disorder were associated with worse quality of life. On average, females had lower quality of life than males. Patients who were married, living as married, divorced, or separated had worse functional impairment compared with patients who were single or never married. A composite score of social disadvantage was associated with worse functioning and marginally associated with worse quality of life. Symptom severity did not moderate the effect of social disadvantage on quality of life or functioning.

conclusionsOur findings highlight that depression, irritability, and psychiatric comorbid conditions negatively impact quality of life and functioning in bipolar disorder. The study suggests that individuals with social disadvantage are at risk for functional impairment. Trial Registration This study is registered with ClinicalTrials.gov. Identification number: NCT01331304.

Indexed as

Bipolar disorderFunctioningQuality of lifeSocial disadvantage

Identifiers

PMID28188565
PMCPMC5366290
OpenAlexW2587007985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.